Here are relevant reports on : reverse-osmosis-ro-membrane-market
-
Spiral Membrane Market by Polymer Type (Polyamide, PS & PES), Technology (RO, NF, UF, and MF), End-use Industry (Water & Wastewater Treatment, Food & Beverage, Pharmaceutical & Biotechnology, Oil & Gas), and Region - Global Forecast to 2023
The spiral membrane market is projected to grow from USD 5.10 billion in 2018 to USD 8.20 billion by 2023, at a CAGR of 10.0% from 2018 to 2023. Spiral membranes are used in a wide range of end-use industries, such as water & wastewater treatment, food & beverages, pharmaceutical & biotechnology, oil & gas, and chemical & petrochemical. They act as a selective barrier, allowing the passage of certain constituents while retaining others. These membranes are mainly termed as filtration elements and are widely used in commercial and industrial applications. With recent developments in spiral membrane materials and increasing demand for the reduction of energy consumption in the chemical processing industry, newer membranes and processes are being developed for new applications.. DowDuPont Inc. (US), Toray Industries, Inc. (US), Hydranautics (US), LG Water Solutions (South Korea), SUEZ Water Technologies and Solutions (France), Merck Group (Germany), Pentair plc (US), Koch Membrane Systems (US), Pall Corporation (US), and Lanxess (Germany) are the key players operating in the spiral membrane market.
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Global Forecast to 2028
The global recombinant proteins market, valued at US$2.1 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.2 billion by the end of the period. Growth in the market can be attributed to factors such as rising incidence of chronic diseases, growing demand for biologics and biosimilars due to expiration of patents, rising demand for customized medicine and increasing government initiatives for R&D in life sciences research.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Roofing Chemicals Market by Type (Acrylic Resin, Asphalt/Bituminous, Elastomer, Epoxy Resin, and Styrene), Application (Membrane, Elastomeric, Bituminous, Metal, and Plastic Roofing Materials) - Global Forecast to 2026
The global roofing chemicals market is projected to reach USD 160.25 Billion by 2026, at a CAGR of 7.8% from 2016 to 2026. Roofing chemicals are experiencing a high demand from the construction sector in the Asia-Pacific region. Expansions and new product development activities undertaken by different companies for more energy efficient solutions are the key factors driving the growth of the global roofing chemicals market. Roofing chemicals helps in maintaining lower temperatures in the interiors of buildings by reflecting the sunlight on roofs. This reduces the energy consumption required to cool buildings.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Asia Pacific Pharmaceutical Filtration Market by Product [Membrane Filter, Depth Filter, Virus Filter, Air Filter, Assemblies, System (Single-use)], Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User-Forecast to 2030
The Asia Pacific pharmaceutical filtration market, valued at USD 3.24 billion in 2024, stood at USD 3.50 billion in 2025 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2030, culminating in a forecasted valuation of USD 5.58 billion by the end of the period. The Asia Pacific pharmaceutical filtration market is experiencing growth, driven by quality regulations, rising demand for sterile drug production, and the increasing adoption of biologic therapies.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
PFAS Filtration Market by Technology (Water Treatment Systems, Water Treatment Chemicals), Place of Treatment (In-situ, Ex-situ), Remediation Technology (Activated Carbon, Ion Exchange Resin, RO Membrane & Nanofiltration), Contaminant Type, Environmental Medium, Service Type, End-use Industry, & Region - Global Forecast to 2031
The PFAS filtration market is expected to reach USD 3.28 billion by 2031 from USD 2.34 billion in 2026, at a CAGR of 7.0% from 2026 to 2031. Prominent key players include are Veolia (France), AECOM (US), WSP (Canada), Clean Earth (US), Xylem (US), Jacobs (US), TRC Companies, Inc. (US), Battelle Memorial Institute (US), Cyclopure (US), John Wood Group plc (UK), Ion Exchange (India), and Ecolab Inc. (US), among others.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Hydrochloric Acid Electrolysis Market by Technology (Membrane Technology, Diaphragm Technology), Application (Polyurethane Industry (MDI/TDI), PVC Production or Chlorination, Fumed Silica Production, Agrochemical, Other Applications), and Region - Global Forecast to 2030
The hydrochloric acid electrolysis market is expected to grow from USD 865.9 million in 2025 to USD 1,009.4 million in 2030, at a CAGR of 3.1% during the forecast period. The report profiles key companies, including thyssenkrupp nucera (Germany), Industrie De Nora S.p.A. (Italy), Covestro AG (Germany), and Bluestar (Beijing) Chemical Machinery Co., Ltd. (China).
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Europe Pharmaceutical Filtration Market by Product [Membrane Filter, Depth Filter, Virus Filter, Air Filter, Assemblies, Systems (Single-use)], Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User - Forecast to 2030
The Europe Pharmaceutical Filtration Market, valued at USD 3.81 billion in 2024, stood at USD 4.05 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of USD 5.95 billion by the end of the period. Pharmaceutical filtration is a process wherein solid and semi-solid particles present in a suspension are separated from a liquid or gas by employing membrane filters, such as filter sheets, cartridges & capsules, papers, depth filters, and others.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Green Ammonia Market by Technology (Alkaline Water Electrolysis (AWE), Proton Exchange Membrane (PEM), Solid Oxide Electrolysis (SOE)) End-Use Application (Transportation, Power Generation, Industrial Feedstock) Capacity, Region -Global Forecast to 2030
The worldwide green ammonia market is projected to reach USD 6.16 billion by 2030, expanding at a CAGR of 66.0% during the forecasting period. Some of the major players in the Green Ammonia market are Siemens Energy (Germany), ACME Group (India), Iberdrola, S.A. (Spain), ThyssenKrupp AG (Germany), Nel ASA (Norway), and Yara (Norway) among others. The major strategies adopted by these players include new product launches, acquisitions, contracts, agreements, partnerships, joint ventures, collaborations, investments, and expansions.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Transfer Membrane Market by Type (PVDF, Nitrocellulose, Nylon), Transfer Method (Tank, Semi-dry, Dry), Application (Western, Northern, Southern Blot, Protein Sequencing), End user (Academia, Diagnolab, Pharmaceutical Companies) - Global Forecast to 2023
The global transfer membrane market is expected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period. Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of transfer membrane market. The key players in the transfer membrane market include Merck KGaA (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Pall Coporation (US), Advansta (US), GVS (Italy), Santa Cruz Biotechnology (US), Abcam (UK), ATTO Corporation (Japan), Carl Roth (Germany), Macherey-Nagel (Germany), Azure Biosystems (US), and Axiva Sichem Biotech (India), among others.
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
US Therapeutic Plasma Exchange Market by Product (Devices, Consumables), Technology (Centrifugation, Membrane Separation), Procedures & Patients (Guillain Syndrome, Multiple Sclerosis, Cryoglobulinemia), End Users & Region - Forecast to 2025
The US therapeutic plasma exchange (TPE) market, valued at $178 million in 2020, is projected to grow to $243 million by 2025, with a CAGR of 6.3%. Growth is fueled by increasing chronic disease prevalence and technological advancements, especially in continuous-flow centrifugation. However, high device costs and a shortage of skilled professionals may hinder growth.
- Published: September 2020
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
